Skip to main content

Overview of the Last 25 Years and 13 International Congresses on Antiphospholipid Antibodies

  • Chapter
  • First Online:
Antiphospholipid Syndrome

Abstract

The topic of antiphospholipid antibodies has generated a significant amount of interest among physicians and researchers of multiple subdisciplines over the last 28 years. Thirteen international congresses have been conducted from 1984 to 2010. This introductory chapter highlights the contents of those scientific gatherings, which clearly depicted the evolution and the continued enthusiasm on gaining new knowledge in the field of Antiphospholipid Syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest. 1952;31:621–2.

    Google Scholar 

  2. Bowie EJ, Thrompson Jr JH, Pascuzzi CA, Owen Jr CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med. 1963;62:416–30.

    CAS  PubMed  Google Scholar 

  3. Nilsson IM, Asstedt B, Hedner U, et al. Intrauterine death and circulating anticoagulant “antithromboplastin”. Acta Med Scand. 1975;197:153–9.

    Article  CAS  PubMed  Google Scholar 

  4. Harris EN. Syndrome of the black swan. Br J Rheumatol. 1987;5:324–6.

    Article  CAS  PubMed  Google Scholar 

  5. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;2:1211–4.

    Article  CAS  PubMed  Google Scholar 

  6. Pierangeli SS, Liu X, Barker JH, Anderson G, Harris EN. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the Antiphospholipid Syndrome. Thromb Haemost. 1995;74:1361–7.

    CAS  PubMed  Google Scholar 

  7. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice: a model of autoimmune fetal loss. Am J Obstet Gynecol. 1990;163:210–6.

    Article  CAS  PubMed  Google Scholar 

  8. Bakimer R, Fishman P, Blank M. et a. Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3). J Clin Invest. 1992;89:1558–63.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Harris EN, Gharavi AE, Patel S, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4 1986. Clin Exp Immunol. 1987;68:215–22.

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Harris EN. The second international anticardiolipin standardization workshop: the Kingston Anticardiolipin Antibody Study (KAPS) group. Am J Clin Pathol. 1990;101:616–26.

    Google Scholar 

  11. Pierangeli SS, Stewart M, Silva LK, Harris EN. Report of an anticardiolipin workshop during the VIIth International Symposium on Antiphospholipid Antibodies. J Rheumatol. 1998;25:156–62.

    CAS  PubMed  Google Scholar 

  12. Harris EN, Pierangeli S, Birch D. Anticardiolipin wet workshop report: Vth International Symposium on Antiphospholipid Antibodies. Am J Clin Pathol. 1994;101:616–24.

    CAS  PubMed  Google Scholar 

  13. Forastiero R, Papalardo E, Watkins M, et al. Evaluation of the performance of monoclonal and polyclonal antibody standards in different assays for the detection of antiphospholipid antibodies: report of a wet workshop at the 13th International Congress on Antiphospholipid (aPL) antibodies. Arthritis Rheum 2010;62:S946 (abstract).

    Google Scholar 

  14. Forastiero, R, Papalardo E, Morin K, et al. Comparative evaluation of different immunoassays for the detection of antiphospholipid antibodies: report of a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum 2010;62:2252 (abstract).

    Google Scholar 

  15. Albesa R, Nelson V, Shums Z, et al. Evaluation of “non-criteria” antiphospholipd (aPL) assays at a wet workshop during the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum 2010;62:2250 (abstract).

    Google Scholar 

  16. Harris EN. Third International Antiphospholipid Conference: barbecues, rum punches and kaps. Ann Rheum Dis 1988;47:612–14 (Conference report).

    Google Scholar 

  17. McNeil HP, Simpson RJ, Cherterman CN, et al. Antiphospholipid antibodies are directed against a complex antigen that includes lipid binding inhibitor of coagulation: β2 glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A. 1990;87:4120–4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335:1544–7.

    Article  CAS  PubMed  Google Scholar 

  19. Matsuura E, Igarashi Y, Fujimoto M, et al. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet. 1990;336:177–8.

    Article  CAS  PubMed  Google Scholar 

  20. Pierangeli SS, Liu XW, Anderson G, et al. Thrombogenic properties of murine anti-cardiolipin antibodies induced by ß2glycoprotein 1 and human IgG antiphospholipid antibodies. Circulation. 1996;94:1746–51.

    Article  CAS  PubMed  Google Scholar 

  21. Pierangeli SS, Colden-Stanfield M, Liu X, et al. Antiphospholipid antibodies from patients with Antiphospholipid Syndrome activate endothelial cells in vitro and in vivo. Circulation. 1999;99:1997–2002.

    Article  Google Scholar 

  22. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 2003;101:157–62.

    Article  CAS  PubMed  Google Scholar 

  23. Fischetti F, Durigutto P, Pellis V, et al. Thrombus formation induced by antibodies to beta2-­glycoprotein I is complement dependent and requires a priming factor. Blood. 2005;106:2340–6.

    Article  CAS  PubMed  Google Scholar 

  24. Pierangeli SS, Vega-Ostertag ME, Raschi E, et al. Toll Like Receptor-4 is involved in antiphospholipid-mediated thrombosis: in vivo studies. Ann Rheum Dis. 2007;66:1327–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Ramesh S, Morrell CN, Tarango C, et al. Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2. J Clin Invest. 2011;121:120–31.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Arad A, Proulle V, Furie RA, Furie BC, Furie B. {Beta}2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 2011;117:3453–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Rai R, Coehn H, Dave M, et al. Randomized controlled trial of aspirian and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipids antibodies (or antiphospholipid antibodies). BMJ. 1997;314:253–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Kutteh WH. Antiphospholipid antibody associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584–9.

    Article  CAS  PubMed  Google Scholar 

  29. Gharavi AE, Sammaritano LR, Wen J, Elkon KB. Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H). J Clin Invest. 1992;90:1105–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Pierangeli SS, Harris EN. Induction of phospholipid binding antibodies in mice and rabbits by immunization with human ß2Glycoprotein 1 or anticardiolipin antibodies alone. Clin Exp Immunol. 1993;93:269–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Wilson WA, Ghavari AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42:1309–11.

    Article  CAS  PubMed  Google Scholar 

  32. Miyakis S, Lockshin MD, Atsumi I, et al. International concensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eon Nigel Harris MD, DM .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Harris, E.N., Pierangeli, S.S. (2012). Overview of the Last 25 Years and 13 International Congresses on Antiphospholipid Antibodies. In: Erkan, D., Pierangeli, S. (eds) Antiphospholipid Syndrome. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-3194-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3194-7_1

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-3193-0

  • Online ISBN: 978-1-4614-3194-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics